Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial
Authors:
- Twt LeungTLTwt Leung
- Skw HoSHSkw Ho
- M ChanMCM Chan
- D MachinDMD Machin
- J LauJLJ Lau
- Atc ChanACAtc Chan
- W YeoWYW Yeo
- Tsk MokTMTsk Mok
- Sch YuSYSch Yu
- Nwy LeungNLNwy Leung
- Pj JohnsonPJPj Johnson
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353 (9155) , 797-801
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Superselective Intra-Arterial Radiometabolic Therapy With I-131 Lipiodol in Hepatocellular CarcinomaClinical Nuclear Medicine, 1996
- Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinomaBritish Journal of Surgery, 1996
- Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patientsCancer, 1995
- Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled LipiodolCancer Chemotherapy and Pharmacology, 1994
- Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinomaCancer, 1993
- Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating CirrhosisAnnals of Surgery, 1991
- Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysisCancer, 1990
- Postoperative Recurrence of Hepatocellular CarcinomaAnnals of Surgery, 1990
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985
- The surgical management of primary carcinoma of the liverWorld Journal of Surgery, 1982